Patient Guide: Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 172 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02000622
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer Metastatic, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation
Phase: PHASE3

Find a Study Location Near You

This study is available at 172 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • San Diego, California
  • Santa Rosa, California
  • Whittier, California
  • • And 169 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily